mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). (Q37539440)
Jump to navigation
Jump to search
scientific article published on July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). |
scientific article published on July 2009 |
Statements
1 reference
mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). (English)
1 reference
Alejandro Vázquez-Martín
1 reference
Cristina Oliveras-Ferraros
1 reference
Sonia del Barco
1 reference
Begoña Martín-Castillo
1 reference
Javier A Menéndez
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference